Search results
Results from the Tech24 Deals Content Network
June 12, 2024 at 9:06 AM. Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive ...
$791 billion. Eli Lilly's market capitalization. Mounjaro and Zepbound, medicines for diabetes and obesity, have driven up the company's share price to make it the world's ninth most valuable company.
One reason it's not too late to buy this stock is that Eli Lilly is making more money than it expected to at the start of the year. Management raised revenue guidance to a ceiling of $46.6 billion ...
For a while, it seemed the streak was over for Eli Lilly (NYSE: LLY). Shares of the big drugmaker skyrocketed nearly 160% between early 2023 and mid-July of this year. However, Lilly's stock ...
Eli Lilly reported significantly better-than-expected earnings Thursday, with revenue coming in 13% higher than Wall Street estimates of $11.3 billion for the second quarter.That's a 36% jump in ...
How does Eli Lilly (NYSE: LLY) follow up on gains of close to 60% in 2023 and so far in 2024? By winning a major U.S. Food and Drug Administration (FDA) approval. Last week, the FDA approved Lilly ...
Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn ...
Eli Lilly’s share price has surged close to 700% over the past five years. Among its newer products are Mounjaro and Zepbound. Both medicines are from the increasingly popular class of drugs ...